Published by Josh White on 29th October 2025
(Sharecast News) - GSK raised its full-year guidance on Wednesday, after delivering stronger-than-expected third-quarter results, driven by robust growth in specialty medicines and steady contributions from its vaccines and general medicines divisions.
URL: http://www.digitallook.com/dl/news/story/35456214/...